Leonardo DRS, Inc. vs Honeywell International Inc. — Stock Comparison
Q·Score Breakdown
7.2
Bullish
Overall
6.8
Neutral
Quality
Health
Growth
Valuation
Sentiment
DRS
Clean balance sheet with low leverage (0.2× debt-to-equity).
⚠ weak profitability metrics drag quality score.
HON
High-quality business with 24% return on equity and 11% profit margins.
⚠ earnings contracting 42% year-over-year.
Analyst Consensus
BUY
Target $52.00 (+29.9%)
10 analysts
BUY
Target $247.90 (+16.7%)
25 analysts
Fundamentals
DRS
HON
38.9×
Trailing P/E
33.9×
28.4×
Forward P/E
18.5×
7.6%
Profit Margin
10.9%
23.8%
Gross Margin
36.9%
10.5%
ROE
24.3%
8.1%
Revenue Growth
2.4%
12.2%
Earnings Growth
-41.9%
0.26
Beta
0.92
—
Price / Book
—
$10.6B
Market Cap
$134.7B
$32 – $49
52-Week Range
$187 – $248
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →